4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-23-007362
President and CEO acquired 10,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sanjay President and CEO | 2023-02-03 | Option exercise | +10,375 | 61,173 | D | ||
| Derivatives | |||||||
| Shukla Sanjay President and CEO | 2023-02-03 | Option exercise · Restricted Stock Unit | −10,375 | 31,125 | D | ||
Loading xslF345X03/doc4.xml…